← Back
$FENC All transactions

FENNEC PHARMACEUTICALS INC.

M

$ Value

$0

Shares

13,943

Price

$0

Filed

Apr 2

Insider

Name

Hackman Jeffrey S.

Title

Chief Executive Officer

CIK

0001926254

Roles

Director Officer

Transaction Details

Transaction Date

2026-03-28

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

60,507

Footnotes

Represents settlement of PSUs that vested on March 31, 2026. | Represents shares released from restriction from shares awarded 3/28/2025. | On March 31, 2026, granted incentive stock options to purchase 200,000 shares of the issuers common shares pursuant to the Issuer's 2020 Equity Incentive Plan. | One-third of the shares subject to this option may be exercised as of March 31, 2027 ("Vesting Commencement Date"). One twenty-fourth of the shares subject to this option shall vest and may be exercised as of the last day of each month following the Vesting Commencement Date. As of March 31, 2029, 100% of the total number of shares subject to this option shall be vested.

Filing Info

Accession No.

0001926254-26-000004

Form Type

4

Issuer CIK

0001211583

Hackman Jeffrey S.'s History

Date Ticker Type Value
2026-03-31 FENC M $0
2026-03-31 FENC M $0
2026-03-31 FENC A $1.2M
2026-03-28 FENC M $0
2026-02-18 FENC M $0
2025-05-19 FENC $98K
2025-05-16 FENC $7K

Other Insiders at FENC (90d)

Insider Bought Sold Last
Andrade Robert
CHIEF FINANCIAL OFFICER
2026-03-31
Raykov Rosty $234K 2026-04-01
Hackman Jeffrey S.
Chief Executive Officer
2026-03-31
Evans Terry L
Chief Commercial Officer
2026-03-31
Sayad Pierre Sargis
Chief Medical Officer
2026-03-31
Cioffi Christiana Marie
Chief Strategy Officer
2026-03-31